Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1987 Jan;79(1):257–264. doi: 10.1172/JCI112792

Steroid-sensitive mechanism of soluble immune response suppressor production in steroid-responsive nephrotic syndrome.

H W Schnaper, T M Aune
PMCID: PMC424035  PMID: 3793925

Abstract

Soluble immune response suppressor (SIRS), a lymphokine that suppresses antibody production and delayed type hypersensitivity in vivo, has been detected in urine and serum from certain patients with nephrotic syndrome. In the present paper, the relationship between SIRS production and nephrotic syndrome is further characterized. A striking correlation was found between detection of SIRS and the presence of steroid-responsive nephrotic syndrome (SRNS). A potential mechanism of SIRS production in SRNS patients was identified, in that lymphocytes from patients produced SIRS without requiring activation by exogenous agents, and incubation of normal lymphocytes with serum from patients activated the cells to secrete SIRS in culture. Although SIRS disappears rapidly from urine or serum after initiation of corticosteroid therapy, hydrocortisone (10(-6)-10(-7) M) did not block secretion of SIRS by activated suppressor cells. It did, however, inhibit in vitro activation of lymphocytes to produce SIRS by concanavalin A, interferon, or SRNS patient serum. The association of suppressor cell activation with SRNS and the sensitivity of both to steroids suggest that the pathogeneses of albuminuria and SIRS production are related.

Full text

PDF
257

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aune T. M. ELISA for the detection of the lymphokine soluble immune response suppressor. J Immunol Methods. 1985 Nov 28;84(1-2):33–44. doi: 10.1016/0022-1759(85)90412-0. [DOI] [PubMed] [Google Scholar]
  2. Aune T. M., Pierce C. W. Activation of a suppressor T-cell pathway by interferon. Proc Natl Acad Sci U S A. 1982 Jun;79(12):3808–3812. doi: 10.1073/pnas.79.12.3808. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Aune T. M., Pierce C. W. Conversion of soluble immune response suppressor to macrophage-derived suppressor factor by peroxide. Proc Natl Acad Sci U S A. 1981 Aug;78(8):5099–5103. doi: 10.1073/pnas.78.8.5099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Aune T. M., Pierce C. W. Inhibition of interferon or soluble immune response suppressor (SIRS) mediated suppression by levamisole. Int J Immunopharmacol. 1983;5(1):91–98. doi: 10.1016/0192-0561(83)90077-2. [DOI] [PubMed] [Google Scholar]
  5. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968;97:77–89. [PubMed] [Google Scholar]
  6. Fodor P., Saitúa M. T., Rodriguez E., González B., Schlesinger L. T-cell dysfunction in minimal-change nephrotic syndrome of childhood. Am J Dis Child. 1982 Aug;136(8):713–717. doi: 10.1001/archpedi.1982.03970440057016. [DOI] [PubMed] [Google Scholar]
  7. Giangiacomo J., Cleary T. G., Cole B. R., Hoffsten P., Robson A. M. Serum immunoglobulins in the nephrotic syndrome. A possible cause of minimal-change nephrotic syndrome. N Engl J Med. 1975 Jul 3;293(1):8–12. doi: 10.1056/NEJM197507032930103. [DOI] [PubMed] [Google Scholar]
  8. Gronowicz E., Coutinho A., Melchers F. A plaque assay for all cells secreting Ig of a given type or class. Eur J Immunol. 1976 Aug;6(8):588–590. doi: 10.1002/eji.1830060812. [DOI] [PubMed] [Google Scholar]
  9. Irons R. D., Pfeifer R. W., Aune T. M., Pierce C. W. Soluble immune response suppressor (SIRS) inhibits microtubule function in vivo and microtubule assembly in vitro. J Immunol. 1984 Oct;133(4):2032–2036. [PubMed] [Google Scholar]
  10. Lange K., Ahmed U., Seligson G., Grover A. Depression of endostreptosin, streptolysin O and streptozyme antibodies in patients with idiopathic nephrosis with and without a nephrotic syndrome. Clin Nephrol. 1981 Jun;15(6):279–285. [PubMed] [Google Scholar]
  11. Lenarsky C., Jordan S. C., Ladisch S. Plasma inhibition of lymphocyte proliferation in nephrotic syndrome: correlation with hyperlipidemia. J Clin Immunol. 1982 Oct;2(4):276–281. doi: 10.1007/BF00915067. [DOI] [PubMed] [Google Scholar]
  12. Matsumoto K., Osakabe K., Katayama H., Hatano M. In vitro lymphocyte dysfunction in lipoid nephrosis mediated by suppressor cells. Nephron. 1982;32(3):270–272. doi: 10.1159/000182863. [DOI] [PubMed] [Google Scholar]
  13. Moorthy A. V., Zimmerman S. W., Burkholder P. M. Inhibition of lymphocyte blastogenesis by plasma of patients with minimal-change nephrotic syndrome. Lancet. 1976 May 29;1(7970):1160–1162. doi: 10.1016/s0140-6736(76)91545-2. [DOI] [PubMed] [Google Scholar]
  14. Rich R. R., Pierce C. W. Biological expressions of lymphocyte activation. 3. Suppression of plaque-forming cell responses in vitro by supernatant fluids from concanavalin A-activated spleen cell cultures. J Immunol. 1974 Apr;112(4):1360–1368. [PubMed] [Google Scholar]
  15. Schaffner A. Therapeutic concentrations of glucocorticoids suppress the antimicrobial activity of human macrophages without impairing their responsiveness to gamma interferon. J Clin Invest. 1985 Nov;76(5):1755–1764. doi: 10.1172/JCI112166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Schnaper H. W., Aune T. M. Identification of the lymphokine soluble immune response suppressor in urine of nephrotic children. J Clin Invest. 1985 Jul;76(1):341–349. doi: 10.1172/JCI111967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Schnaper H. W., Aune T. M., Pierce C. W. Suppressor T cell activation by human leukocyte interferon. J Immunol. 1983 Nov;131(5):2301–2306. [PubMed] [Google Scholar]
  18. Schnaper H. W., Aune T. M. Suppression of immune responses to sheep erythrocytes by the lymphokine soluble immune response suppressor (SIRS) in vivo. J Immunol. 1986 Aug 1;137(3):863–867. [PubMed] [Google Scholar]
  19. Schnaper H. W., Pierce C. W., Aune T. M. Identification and initial characterization of concanavalin A- and interferon-induced human suppressor factors: evidence for a human equivalent of murine soluble immune response suppressor (SIRS). J Immunol. 1984 May;132(5):2429–2435. [PubMed] [Google Scholar]
  20. Shalhoub R. J. Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet. 1974 Sep 7;2(7880):556–560. doi: 10.1016/s0140-6736(74)91880-7. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES